Table 5.
Model type | OR (95% CI) | p-Value |
---|---|---|
Unadjusted model | ||
Liver metastasis at ICI initiation | 2.14 (1.15 to 3.96) | 0.015 |
History of cirrhosis | 0.40 (0.14 to 1.11) | 0.080 |
Adjusted model 1—adjusted for ECOG Performance Score, history of autoimmune disease, Hepatitis B and Hepatitis C | ||
Liver metastasis at ICI initiation | 2.46 (1.25 to 4.85) | 0.009 |
History of cirrhosis | 0.14 (0.02 to 0.74) | 0.020 |
Adjusted model 2—adjusted for dual ICI, ECOG Performance Score, history of autoimmune disease, Hepatitis B and Hepatitis C | ||
Liver metastasis at ICI initiation | 2.79 (1.37 to 5.66) | 0.005 |
History of cirrhosis | 0.14 (0.02 to 0.75) | 0.022 |
CI confidence interval, ECOG Eastern Cooperative Oncology Group, ICI immune checkpoint inhibitor, irH immune-related hepatitis, OR odds ratio